Prognosis of IntraCerebral Haemorrhage (PITCH)

Principal Investigator

Charlotte Cordonnier
Centre Hospitalier Régional Universitaire de Lille,
Department of Neurology & Stroke Unit,
Hopital Roger Salengro,
59037 Lille, France.
Charlotte.cordonnier@chru-lille.fr

Summary

Country France
Principal Investigator Charlotte Cordonnier
Contact person (email) Charlotte.cordonnier@chru-lille.fr<
Key publication/reference Cordonnier et al. Brain 2010; 133: 3281-9
Years in which study conducted 2004-2009
Sample  
Size 562
Population: Hospital/community Hospital
Selection: consecutive/random Consecutive
Admit with previous stroke? Yes
Admit with TIA? No
Age range Median 72 (IQR 58-79); no age limit for inclusion
Number of centres 1
Control group: number, population, selection None
Assessment  
Initial: Time and data collected/tests administered At admission: MedHx, VRF
Day 7: Neurological exam, glucose, renal, hb, white cells, cholesterol, ECG, CT, MRI, IQCODE
Detailed Discharge: function
Subsequent (follow-ups) NΨ: 6m, 1y, 2y, 3y, 4.5y, 6y, 8y, 10y
Stroke-related data NIHSS
Functional tests/data Barthel Index, Rankin Scale
Other medical tests/data Fatigue, seizures
Neuropsychological tests Test battery, MMSE, Mattis
MRI scans, when and how many At admission, 6m, 2y, 4.5y, 6y, 8y, 10y
PET scans No
Psychiatric exams/diagnoses Dementia, anxiety, depression (MADRS)
Intervention trialled? No

CT=computed tomography scan, MedHx=medical history, VRF=vascular risk factors (hypertension, diabetes, atrial fibrillation, obesity, smoking etc.), NΨ=neuropsychological, TIA=transient ischemic attack, m=month, y=year